COLL Collegium Pharmaceutical Inc.

10.95
-0.29  -3%
Previous Close 11.24
Open 11.13
Price To Book 4.23
Market Cap 365,607,429
Shares 33,386,672
Volume 72,068
Short Ratio
Av. Daily Volume 340,857

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approval announced November 7, 2017.
Xtampza ER (oxycodone)
Severe pain
Approved April 26 2016
Xtampza ER (oxycodone)
Severe pain

Latest News

  1. Edited Transcript of COLL earnings conference call or presentation 8-May-19 8:30pm GMT
  2. Hedge Funds Have Never Been This Bullish On Collegium Pharmaceutical Inc (COLL)
  3. Collegium to Present at Upcoming Investor Conferences
  4. Collegium Pharmaceutical, Inc. (COLL) Q1 2019 Earnings Call Transcript
  5. Were Hedge Funds Right About Dumping Collegium Pharmaceutical Inc (COLL) ?
  6. Assertio Therapeutics, Inc (ASRT) Q1 2019 Earnings Call Transcript
  7. Collegium Pharmaceutical (COLL) Reports Q1 Loss, Tops Revenue Estimates
  8. Collegium Pharmaceutical: 1Q Earnings Snapshot
  9. Collegium Reports First Quarter 2019 Financial Results
  10. Assertio Therapeutics (ASRT) to Post Q1 Earnings: What's Up?
  11. 2 Big Biotech Stock Upgrades: Can They Reach These Targets?
  12. Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy?
  13. Collegium to Participate in Upcoming Investor Conferences
  14. Collegium to Host Conference Call to Discuss First Quarter 2019 Financial Results and Provide Corporate Update
  15. Collegium Appoints Richard Malamut, M.D., as Chief Medical Officer
  16. Read This Before Buying Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares
  17. Collegium Pharmaceutical (COLL) Upgraded to Buy: What Does It Mean for the Stock?
  18. Assertio Therapeutics, Inc (ASRT) Q4 2018 Earnings Conference Call Transcript
  19. Edited Transcript of COLL earnings conference call or presentation 27-Feb-19 9:30pm GMT